A Study to Evaluate Safety and Efficacy of APO-2 at Three Different Doses in Patients With Diabetic Foot Ulcer

NCT04277598 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

159

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetic Foot Ulcer (DFU)

Interventions

BIOLOGICAL: APO-2
OTHER: Placebo

Sponsor

Aposcience AG

Collaborators

[object Object]